Results 221 to 230 of about 78,455 (315)
Gene expression and epigenetic markers of prion diseases. [PDF]
Viré EA, Mead S.
europepmc +1 more source
Innate Immune tolerance in microglia does not impact on CNS prion disease
Pal, Reiss +2 more
openalex +1 more source
Extracellular vesicles (EVs) are tiny, membrane‐covered packets that cells naturally release to send molecular information to one another. In the brain, they function as couriers that move proteins, lipids, and other signals between neurons, glial cells, and the blood–brain barrier.
Berenice N. Bernal‐Vicente +4 more
wiley +1 more source
Reactive microglia partially envelop viable neurons in prion diseases. [PDF]
Makarava N +9 more
europepmc +1 more source
On the reactive states of astrocytes in prion diseases. [PDF]
Baskakov IV.
europepmc +1 more source
ABSTRACT Gastrointestinal (GI) cancers remain a leading cause of global morbidity and mortality, necessitating novel therapeutic strategies. Melatonin (MEL), an indoleamine with pleiotropic biological activities, has emerged as a promising adjuvant in oncology due to its antiproliferative, proapoptotic, and antioxidant properties.
Maciej Gonciarz +4 more
wiley +1 more source
Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. [PDF]
Caredio D +13 more
europepmc +1 more source
Revealing the Mysterious Veil of Prion Diseases Under the Framework of China CDC. [PDF]
Dong X.
europepmc +1 more source
Abstract In the coming decades, there is expected to be a sharply increased demand for dietary proteins for humans and animals. As a result, there is an increasing focus on reared insects as a new source of protein. According to the Ministry of Agriculture, Nature and Food Quality (LNV), the use of food chain residual flows such as former foodstuffs as
L.F.F. Kox, D.T.H.M. Sijm
wiley +1 more source
Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases. [PDF]
Wen P +11 more
europepmc +1 more source

